Elequin Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Buy
+307
New +$24.8K ﹤0.01% 396
2024
Q1
– Sell
-2,800
Closed -$231K – 385
2023
Q4
$231K Buy
+2,800
New +$213K 0.07% 107

Other funds holding MDT

Elequin Capital's MDT Position: Q2 2026 in Review

Elequin Capital opened a new position in Medtronic (MDT) in Q2 2026: 307 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #396 among its holdings. This is a return to the name: Elequin Capital previously reported a position in MDT as recently as Q4 2023.

Elequin Capital first reported a position in MDT in Q4 2023 and has held it in 2 quarters since. The position peaked at $231K in Q4 2023. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Elequin Capital held 307 shares of Medtronic worth $24K as of Q2 2026.
  • Medtronic was a new Elequin Capital position in Q2 2026.
  • Medtronic made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #396 holding.
  • Elequin Capital first reported a position in Medtronic in Q4 2023 and has held it in 2 quarters since.
  • Elequin Capital's Medtronic position peaked at $231K in Q4 2023.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.